DLRHX
Price
$25.89
Change
+$0.20 (+0.78%)
Updated
Feb 13 closing price
Net Assets
706.12M
JFNIX
Price
$81.95
Change
+$0.15 (+0.18%)
Updated
Feb 13 closing price
Net Assets
5.4B
Interact to see
Advertisement

DLRHX vs JFNIX

Header iconDLRHX vs JFNIX Comparison
Open Charts DLRHX vs JFNIXBanner chart's image
Nomura Healthcare Fund
Price$25.89
Change+$0.20 (+0.78%)
VolumeN/A
Net Assets706.12M
Janus Henderson Global Life Sciences I
Price$81.95
Change+$0.15 (+0.18%)
VolumeN/A
Net Assets5.4B
DLRHX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
DLRHX vs. JFNIX commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLRHX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 5.4B vs. DLRHX (706M). DLRHX pays higher dividends than JFNIX: DLRHX (2.29) vs JFNIX (0.45). DLRHX was incepted earlier than JFNIX: DLRHX (16 years) vs JFNIX (17 years). DLRHX (1.51) is less costly to investors than JFNIX (0.78). JFNIX is a more actively managed with annual turnover of: 30.00 vs. DLRHX (5.00). DLRHX has a lower initial minimum investment than JFNIX: DLRHX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : 15.20 vs. DLRHX (7.43). JFNIX return over 5 years is better than : 13.85 vs. DLRHX (-10.68).
DLRHXJFNIXDLRHX / JFNIX
Total Expense Ratio1.460.78187%
Annual Report Gross Expense Ratio1.510.78194%
Fund Existence16 years17 years-
Gain YTD2.9010.973298%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets706M5.4B13%
Annual Yield % from dividends2.290.45515%
Returns for 1 year7.4315.2049%
Returns for 3 years7.4124.3830%
Returns for 5 years-10.6813.85-77%
Returns for 10 years57.1496.9359%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AHSZX24.260.17
+0.71%
Alger Health Sciences Z
MVGKX18.330.10
+0.55%
MFS Low Volatility Global Equity R2
MDIIX20.830.05
+0.24%
iShares MSCI EAFE Intl Idx Inv A
FFNTX14.440.03
+0.21%
Fidelity Advisor Asset Manager 40% M
TEUIX25.81-0.03
-0.12%
T. Rowe Price European Stock I